MedPage Today June 18, 2020
— Could ease access to expensive therapies, experts say
WASHINGTON — State Medicaid operations and Medicaid managed care plans will have more opportunities to use value-based purchasing arrangements for pharmaceuticals under a proposed rule from the Centers for Medicare & Medicaid Services (CMS).
“This proposed rule really creates the pathway for private insurance companies to enter into value-based agreements with manufacturers,” CMS Administrator Seema Verma said on a call with reporters Wednesday evening. “Value-based payments generally are taking a hold of the healthcare system. This proposal doesn’t necessarily guarantee lower prices, but it provides a tool in the toolbox for plans to negotiate with manufacturers. It also shifts us away from our typical negotiations around drug pricing — which are...
Today's Sponsors
Today's Sponsor